PMI Stock Up 9,186% after 5-Day Win Streak
Picard Medical (PMI) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 9,186% return. The company has gained about $NaN in value over the last 5 days, with its current market capitalization at about $NaN. The stock remains 9185.7% above its value at the end of 2024. This compares with year-to-date returns of 10.2% for the S&P 500.
PMI no company description provided to compress. Please provide the description for assistance.
Comparing PMI Stock Returns With The S&P 500
The following table summarizes the return for PMI stock vs. the S&P 500 index over different periods, including the current streak:
- The Next Big Rally in Ford Motor Stock Could Start Like This
- The Risk Factors to Watch Out For in NVIDIA Stock
- Intuitive Surgical Stock Now 16% Cheaper, Time To Buy
- AT&T Stock Pays Out $85 Bil – Investors Take Note
- Intel Stock Pays Out $92 Bil – Investors Take Note
- Comcast Stock Capital Return Hits $44 Bil
| Return Period | PMI | S&P 500 |
|---|---|---|
| 1D | 2.1% | -0.3% |
| 5D (Current Streak) | 9185.7% | -0.3% |
| 1M (21D) | 9185.7% | 2.2% |
| 3M (63D) | 9185.7% | 9.1% |
| YTD 2025 | 9185.7% | 10.2% |
| 2024 | 0.0% | 23.3% |
| 2023 | 0.0% | 24.2% |
| 2022 | 0.0% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 88 S&P constituents with 3 days or more of consecutive gains and 23 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 69 | 10 |
| 4D | 8 | 6 |
| 5D | 7 | 6 |
| 6D | 3 | 1 |
| 7D or more | 1 | 0 |
| Total >=3 D | 88 | 23 |
Key Financials for Picard Medical (PMI)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $5.0 Mil | $4.4 Mil |
| Operating Income | $-15.5 Mil | $-13.7 Mil |
| Net Income | $-15.6 Mil | $-21.1 Mil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $0.8 Mil | $0.6 Mil |
| Operating Income | $-3.6 Mil | $-3.2 Mil |
| Net Income | $-8.8 Mil | $-5.6 Mil |
While PMI stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.